Xeris Biopharma Holdings Historical PE Ratio image   This XERS PE ratio history page last updated 5/11/2023
Xeris Biopharma Holdings Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2023
5/9/2023
2.73-0.12-0.48NA
Q4 2022
3/8/2023
1.35-0.10-0.40NA
Q3 2022
11/9/2022
1.48-0.16-0.64NA
Q2 2022
8/10/2022
1.93-0.19-0.76NA
Q1 2022
5/11/2022
1.64-0.25-1.00NA
Q4 2021
3/10/2022
2.62-0.42-1.68NA
Q3 2021
11/10/2021
1.90-0.39-1.56NA
Q2 2021
8/5/2021
2.48-0.41-1.64NA
Q1 2021
5/13/2021
3.19-0.30-1.20NA
Q4 2020
3/9/2021
4.61-0.41-1.64NA
Q3 2020
11/9/2020
5.74-0.35-1.40NA
Q2 2020
8/10/2020
3.52-0.63-2.52NA
Q1 2020
5/7/2020
2.72-0.89-3.56NA
Q4 2019
3/11/2020
2.22-1.23-4.92NA
Q3 2019
11/7/2019
8.23-1.22-4.88NA
Q2 2019
8/6/2019
9.96-1.28-5.12NA
Q1 2019
5/9/2019
11.62-1.07-4.28NA
Q4 2018
3/6/2019
10.32-0.98-3.92NA
Q3 2018
11/7/2018
24.46-0.71-2.84NA
Xeris Biopharma Holdings PE History Chart
PeriodPriceGAAPTTMPE
Q1 2023
5/9/2023
2.73-0.12-0.57NA
Q4 2022
3/8/2023
1.35-0.10-0.70NA
Q3 2022
11/9/2022
1.48-0.16-1.02NA
Q2 2022
8/10/2022
1.93-0.19-1.25NA
Q1 2022
5/11/2022
1.64-0.25-1.47NA
Q4 2021
3/10/2022
2.62-0.42-1.52NA
Q3 2021
11/10/2021
1.90-0.39-1.51NA
Q2 2021
8/5/2021
2.48-0.41-1.47NA
Q1 2021
5/13/2021
3.19-0.30-1.69NA
Q4 2020
3/9/2021
4.61-0.41-2.28NA
Q3 2020
11/9/2020
5.74-0.35-3.10NA
Q2 2020
8/10/2020
3.52-0.63-3.97NA
Q1 2020
5/7/2020
2.72-0.89-4.62NA
Q4 2019
3/11/2020
2.22-1.23-4.80NA
Q3 2019
11/7/2019
8.23-1.22-4.55NA
Q2 2019
8/6/2019
9.96-1.28-4.04NA
Q1 2019
5/9/2019
11.62-1.07NANA
Q4 2018
3/6/2019
10.32-0.98NANA
Q3 2018
11/7/2018
24.46-0.71NANA
Quotes delayed 20 minutes

Email EnvelopeFree XERS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Xeris Biopharma Holdings (XERS) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

XFOR PE Ratio History
XGN PE Ratio History
XLO PE Ratio History
XLRN PE Ratio History
XNCR PE Ratio History
XOMA PE Ratio History
XRAY PE Ratio History
YMAB PE Ratio History
YMTX PE Ratio History
YTEN PE Ratio History
How should the XERS historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Xeris Biopharma Holdings. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this XERS Historical PE Ratio page.

What is the average historical PE for XERS based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The XERS historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for XERS based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The XERS historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Xeris Biopharma Holdings Historical PE Ratio information for Xeris Biopharma Holdings' stock. The average XERS historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average XERS historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this XERS historical PE result, against the recent PE: when this page was posted on 5/10/2023, the most recent closing price for XERS had been 2.93, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on XERS or any other given stock, valuation analysis for XERS can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Xeris Biopharma Holdings PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for XERS. Thanks for visiting, and the next time you need to research XERS Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: TRTL YTD Return, FDV Historical Stock Prices, Kroger Average Annual Return.

 

Xeris Biopharma Holdings Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 7.8%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 7.8%.